Wenyu Li
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 14
- Advanced biosensing and bioanalysis techniques 10
- DNA and Nucleic Acid Chemistry 5
- Cancer Research top 10%
- MicroRNA in disease regulation 5
- Immunology top 10%
- Oncology top 10%
-
- Thyroid Disorders and Treatments 3
-
- Multiple Sclerosis Research Studies 4
-
- Cardiac Imaging and Diagnostics 3
-
- Systemic Lupus Erythematosus Research 3
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Wenyu Li
56 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Molecular Biology 1.7k
- Cancer Research 214
- Immunology 270
- Oncology 341
- Endocrinology, Diabetes and Metabolism 187
Countries citing papers authored by Wenyu Li
This map shows the geographic impact of Wenyu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyu Li more than expected).
Fields of papers citing papers by Wenyu Li
This network shows the impact of papers produced by Wenyu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyu Li. The network helps show where Wenyu Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenyu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 47 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 18 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 2 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 28 | |
| 11 | 2021 | 93 | |
| 12 | Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndromebreakdown → | 2020 | 260 |
| 13 | 2019 | 15 | |
| 14 | 2017 | 34 | |
| 15 | 2015 | 17 | |
| 16 | 2013 | 35 | |
| 17 | 2013 | 41 | |
| 18 | 2011 | 24 | |
| 19 | 2011 | 32 | |
| 20 | 2002 | 163 |
About Wenyu Li
Wenyu Li is a scholar working on Aging, Molecular Biology and Cancer Research, having authored 60 papers that have together received 2.6k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), Advanced biosensing and bioanalysis techniques (10 papers), DNA and Nucleic Acid Chemistry (5 papers), MicroRNA in disease regulation (5 papers), Multiple Sclerosis Research Studies (4 papers), Cardiac Imaging and Diagnostics (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Thyroid Disorders and Treatments (3 papers). The work is most often cited by research in Molecular Biology (1.7k citations), Cancer Research (214 citations) and Immunology (270 citations). Wenyu Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yigong Shi, Jia-Wei Wu, Muyang Li, Tingting Yao, Wei Gu, Pingwei Li, Robert E. Cohen, Min Hu, Jijie Chai and Robert Schwarzenbacher. Their work appears in journals such as Nature, Cell and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.